Published in Lab Law Weekly, February 2nd, 2007
Naprelan extended-release tablets are a nonsteroidal anti-inflammatory, licensed by Hi-Tech from Elan Pharmaceuticals, Inc. Victory, based in San Diego, California, will promote Naprelan directly to physicians through its sales and marketing force. Hi-Tech concurrently terminated the marketing and distribution agreement with Blansett Pharmacal, its previous marketing partner.
Additionally, Hi-Tech has signed an agreement to sell Naprelan to Victory Pharma subject to the satisfaction of certain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.